Cannabis Use Disorder: A Review on Clinical Management

• DOI: https://doi.org/10.22533/at.ed.1595262514078

• Palavras-chave: --

• Keywords: ---

• Abstract:

  Cannabis Use Disorder (CUD) has become a growing concern in global public health, especially in the face of increasing social permissiveness and changes in cannabis legalization policies. Despite the perception of low risk, chronic use of the substance is associated with cognitive impairment, behavioral changes and the development of dependence, especially withdrawal syndrome, which hinders adherence to treatment and contributes to relapses. This literature review, based on publications from the last five years, aimed to analyze the main therapeutic strategies available for the clinical management of SUD.
  The results indicate the absence of approved pharmacotherapies, despite studies with drugs such as dronabinol, gabapentin and nabilone. On the other hand, non-pharmacological interventions - such as cognitive-behavioral therapy, motivational counseling and psychosocial support - show greater acceptance among users. Digital technologies, such as mobile applications and real-time monitoring tools, are showing promise, but still face implementation barriers. In addition, nutritional counseling has emerged as a relevant complementary strategy, helping to regulate mood, sleep and appetite during abstinence.
  It is concluded that the management of SUD should be multifactorial, individualized and integrative, considering clinical, psychosocial, nutritional and technological aspects. Increased access to treatment, professional training and the development of clinical guidelines based on